It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: MonkeyBalls2
a reply to: CrazeeWorld777
I added an edit, there are at least 6 countries reporting the same sort of symptoms in children.
originally posted by: MonkeyBalls2
From Reuters :
" Three U.S. children infected with the coronavirus are being treated for a rare inflammatory syndrome that appears similar to one that has raised concerns by doctors in Britain, Italy and Spain "
All three - who range in age from 6 months to 8 years - have undergone treatment at Columbia University Medical Center in New York, and all had fever and inflammation of the heart and the gut.
“Right now, we’re at the very beginning of trying to understand what that represents,” Columbia’s Dr. Mark Gorelik told Reuters.
Gorelik, a pediatric rheumatologist and immunologist, said he was called in to consult on the cases to evaluate whether the children have Kawasaki disease, an illness thought to be linked to infection that in severe cases causes inflammation of the arteries of the heart.
More at the link.
edit : More From the Gu ardian Live Feed, at 7pm
Doctors around the world have reported more cases of a rare but potentially lethal inflammatory syndrome in children that appears to be linked to coronavirus infections, Ian Sample and Denis Campbell report.
Nearly 100 cases of the unusual illness have emerged in at least six countries, with doctors in Britain, the US, France, Italy, Spain and Switzerland now reported to be investigating the condition.
The first cases came to light this week when the NHS issued an alert to paediatricians about a number of children admitted to intensive care units with a mix of toxic shock and a condition known as Kawasaki disease, an inflammatory disorder that affects the blood vessel, heart and other organs. So far 19 children have been affected in the UK and none have died.
The French health minister, Olivier Veran, said on Wednesday that the country had more than a dozen children with inflammation around the heart, and while there was insufficient evidence to prove a link with coronavirus, he said the cases were being taken “very seriously.”
Veran told Franceinfo news radio he had received an alert from Paris concerning “about 15 children of all ages”, adding that other cases had been reported in Spain, Italy and Switzerland. He listed the symptoms as fever, digestive problems and vascular inflammation.
Guardian Article on this.
A recent population‐based study has shown that vaccinations did not increase the risk of Kawasaki disease (KD).1 In contrast, various vaccines, including those against rotavirus, hepatitis B, and influenza, have been suggested to be triggers for KD occurrence.2 We report a pediatric case of KD that occurred after simultaneous immunization with measles/rubella, varicella, and pneumococcal vaccine, suggesting that the vaccination is associated with KD.
originally posted by: MrRCflying
Kinda sounds like Remdesivir is a flop.
The article is saying it works, kind of. Symptoms shortened to 11 days from 15, and deaths decreased to 8% from 11% in the study.
I guess some help is better than none, but IMHO it is far from what is needed. Definatley not a jump up and down moment.
Remdesivir[/q uote]
edit on 29-4-2020 by Observationalist because: (no reason given)edit on 29-4-2020 by Observationalist because: (no reason given)edit on 29-4-2020 by Observationalist because: (no reason given)
originally posted by: Observationalist
What do you want. This is a virus we have no idea about. Progress in any war is worth celebrating. The efforts of those fighting to save even just one life should not be diminished just because it does not fit a unicorn solution that for some reason you and many are looking for. Let’s learn from this an push on
originally posted by: MrRCflying
Kinda sounds like Remdesivir is a flop.
The article is saying it works, kind of. Symptoms shortened to 11 days from 15, and deaths decreased to 8% from 11% in the study.
I guess some help is better than none, but IMHO it is far from what is needed. Definatley not a jump up and down moment.
Remdesivir[/q uote]
Well, sure, time to try another med. Last I heard there were dozens that were on the table. Something should work to at least help. It is a step forward, although a small one.
I am not looking for a "unicorn solution", I am not even sure what that means. LOL
I was just pointing out that the results were not all that impressive. If it saves a life, I am all for it. The numbers though could be in the margin of error.
Forward with more testing I guess.
originally posted by: MrRCflying
Kinda sounds like Remdesivir is a flop.
The article is saying it works, kind of. Symptoms shortened to 11 days from 15, and deaths decreased to 8% from 11% in the study.
I guess some help is better than none, but IMHO it is far from what is needed. Definatley not a jump up and down moment.
Remdesivir
originally posted by: cirrus12
Yeah i miss AMEDDOC posts, he was really knowledgeable
a reply to: timewarpedbrain7
originally posted by: FinallyAwake
originally posted by: buddha
This on Fox news.
ER doctors now [say] 'It's interesting when I'm writing about my death report, I'm being pressured to add COVID. Why is that?
well every one knows now!
lets just hope some thing comes of this.
Playing devils advocate only, here's a link from a disease specialist debunking them;
www.mercurynews.com...
And here's a bit about the guy debunking them;
www.cnbc.com...
That's from cnbc so salt needed. 👍🏻
State officials have stopped releasing the list of coronavirus deaths being compiled by Florida’s medical examiners, which has at times shown a higher death toll than the state’s published count.
The list had previously been released in real time by the state Medical Examiners Commission. But earlier this month, after the Tampa Bay Times reported that the medical examiners’ death count was 10 percent higher than the figure released by the Florida Department of Health, state officials said the list needed to be reviewed and possibly redacted.
They’ve now been withholding it for nine days, without providing any of the information or specifying what they plan to remove.
The agency has attempted at least once to block information about deaths from COVID-19, the disease caused by the novel coronavirus, from becoming public.
Last month, it tried to persuade the medical examiner’s office in Miami-Dade County to restrict access to its death records, according to the Miami Herald and correspondence between the two agencies obtained by the Times.
originally posted by: alphabetaone
Remdesivir does seem to be gaining ground though. Shares in Gilead were up 3% on the news that more than half of 397 patients recovered from serious COVID-19 illness and released.
Their study was single-arm though, so I imagine until there's an actual control group study, we wont know the real story.
Article Here
originally posted by: carewemust
originally posted by: alphabetaone
Remdesivir does seem to be gaining ground though. Shares in Gilead were up 3% on the news that more than half of 397 patients recovered from serious COVID-19 illness and released.
Their study was single-arm though, so I imagine until there's an actual control group study, we wont know the real story.
Article Here
FYI: China patented Remsvidir, the drug touted by Dr. Fauci today.
www.dailymail.co.uk...
On January 21, a patent for commercial use of Remdesivir – a drug initially created by an American pharmaceutical firm to fight ebola – was filed in China.
originally posted by: carewemust
And only .03% of Americans have died
Ebola[edit]
On 9 October 2015, the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) announced preclinical results that remdesivir had blocked the Ebola virus in Rhesus monkeys. Travis Warren, who has been a USAMRIID principal investigator since 2007, said that the "work is a result of the continuing collaboration between USAMRIID and Gilead Sciences". The "initial screening" of the "Gilead Sciences compound library to find molecules with promising antiviral activity" was performed by scientists at the Centers for Disease Control and Prevention (CDC). As a result of this work, it was recommended that remdesivir "should be further developed as a potential treatment."
Remdesivir was rapidly pushed through clinical trials due to the West African Ebola virus epidemic of 2013–2016, eventually being used in people with the disease. Preliminary results were promising; it was used in the emergency setting during the Kivu Ebola epidemic that started in 2018, along with further clinical trials, until August 2019, when Congolese health officials announced that it was significantly less effective than monoclonal antibody treatments such as mAb114 and REGN-EB3. The trials, however, established its safety profile.